| 1 |
Xie J, Yang Y, Gao Y, He J. Cuproptosis: mechanisms and links with cancers. Mol Cancer 2023;22:46. [PMID: 36882769 DOI: 10.1186/s12943-023-01732-y] [Reference Citation Analysis]
|
| 2 |
Zhong L, Zhu J, Shu Q, Xu G, He C, Fang L. A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma. J Oncol 2023;2023:5925935. [PMID: 36844874 DOI: 10.1155/2023/5925935] [Reference Citation Analysis]
|
| 3 |
Zhang B, Zhang T, Zheng Z, Lin Z, Wang Q, Zheng D, Chen Z, Ma Y. Development and validation of a cuproptosis-associated prognostic model for diffuse large B-cell lymphoma. Front Oncol 2022;12:1020566. [PMID: 36713586 DOI: 10.3389/fonc.2022.1020566] [Reference Citation Analysis]
|
| 4 |
Wang X, Chen G, Pan C, Liu Y. Editorial: Ferroptosis in cancer and beyond. Front Mol Biosci 2022;9:1115974. [PMID: 36660428 DOI: 10.3389/fmolb.2022.1115974] [Reference Citation Analysis]
|
| 5 |
Li Y, Song K, Zheng W. The Cuproptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Immune Cell Infiltration in Hepatocellular Carcinoma. J Oncol 2023;2023:9557690. [PMID: 36891559 DOI: 10.1155/2023/9557690] [Reference Citation Analysis]
|
| 6 |
Huang T, Liu Y, Li J, Shi B, Shan Z, Shi Z, Yang Z. Insights into prognosis and immune infiltration of cuproptosis-related genes in breast cancer. Front Immunol 2022;13:1054305. [PMID: 36518756 DOI: 10.3389/fimmu.2022.1054305] [Reference Citation Analysis]
|
| 7 |
Tu H, Zhang Q, Xue L, Bao J. Cuproptosis-Related lncRNA Gene Signature Establishes a Prognostic Model of Gastric Adenocarcinoma and Evaluate the Effect of Antineoplastic Drugs. Genes (Basel) 2022;13. [PMID: 36553481 DOI: 10.3390/genes13122214] [Reference Citation Analysis]
|
| 8 |
Liu X, Cheng W, Li H, Song Y. Identification and validation of cuproptosis-related LncRNA signatures as a novel prognostic model for head and neck squamous cell cancer. Cancer Cell Int 2022;22:345. [DOI: 10.1186/s12935-022-02762-0] [Reference Citation Analysis]
|
| 9 |
Ye S, Liu Y, Zhang T, Feng H, Liu Y, Ma L. Analysis of the correlation between non-alcoholic fatty liver disease and the risk of colorectal neoplasms. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1068432] [Reference Citation Analysis]
|
| 10 |
Zhang Q, Ma L, Zhou H, Zhou Y, Liu S, Li Q. A prognostic signature of cuproptosis and TCA-related genes for hepatocellular carcinoma. Front Oncol 2022;12:1040736. [DOI: 10.3389/fonc.2022.1040736] [Reference Citation Analysis]
|
